** Shares of Indian drugmaker Eris Lifesciences Ltd
ERIS.NS rise as much as 3.4% to 605.6 rupees
** Stock set to snap six straight sessions of losses if
gains hold
** Co buys nine dermatology brands from Dr. Reddy's
Laboratories REDY.NS for 2.75 billion rupees ($33.31 million)
** Acquisition to strengthen co's presence in fast-growing
cosmetic dermatology segment- Nirmal Bang analysts
** While deal will expand dermatology offerings of ERIS,
brokerage Prabhudas Lilladher sees it as diluting earnings per
share (EPS) in near term
** Stock trading below 50-day, 100-day and 200-day simple
moving avgs
** More than 150,000 shares change hands by 1:27 a.m. IST,
7.2x 30-day avg of 21,008 shares
** All 10 analysts covering stock have a "buy" or "strong
buy" rating; median PT is 802 rupees - Refinitiv data
** Stock down 9.5% YTD up to last close, fell 14.8% in 2022
($1 = 82.5675 Indian rupees)
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com ;))